121 related articles for article (PubMed ID: 3602063)
1. 30 years of 5-fluorouracil.
Wasternack C; Hause B
Pharmazie; 1987 Feb; 42(2):73-9. PubMed ID: 3602063
[No Abstract] [Full Text] [Related]
2. Syntheses and biological activities of N1-(2-formylethyl)-5-fluorouracil and related compounds.
Kawase M; Samejima K; Okada M; Ochi K; Matsunaga I
Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2395-402. PubMed ID: 4064198
[No Abstract] [Full Text] [Related]
3. N-Alkylated derivatives of 5-fluorouracil.
Kundu NG; Schmitz SA
J Pharm Sci; 1982 Aug; 71(8):935-8. PubMed ID: 7120102
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of 5-fluoro-4-(furfurylideneaminooxy)hexahydro-2,6-dioxo-5-pyrim idinecarb oxylates.
Okutani T; Ukawa K; Yamamoto H; Amano T; Nomura H; Ootsu K; Kozai Y
Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):713-9. PubMed ID: 3708727
[No Abstract] [Full Text] [Related]
5. 5-Fluorouracil derivatives. XII. Synthesis and antitumor activity of alpha-alkylthiomethyl-, alpha-alkylsulfinylmethyl-, alpha-alkylsulfonylmethyl-, and alpha-acylthiomethyl-5-fluorouracils.
Ozaki S; Nagase T; Tamai H; Mori H; Hoshi A; Iigo M
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3894-7. PubMed ID: 3435984
[No Abstract] [Full Text] [Related]
6. A facile method for synthesis of N-acyloxymethyl-5-fluorouracils, as a class of antitumor agents.
Ahmad S; Ozaki S; Nagase T; Iigo M; Tokuzen R; Hoshi A
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4137-43. PubMed ID: 3435940
[No Abstract] [Full Text] [Related]
7. Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivatives.
Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Nakazato K; Ichikawa K; Fukawa K; Irino O; Nishimura N; Okada T
J Med Chem; 1982 Oct; 25(10):1219-22. PubMed ID: 7143359
[No Abstract] [Full Text] [Related]
8. 5-Fluorouracil (FUra).
Valeriote F; Santelli G
Pharmacol Ther; 1984; 24(1):107-32. PubMed ID: 6203132
[No Abstract] [Full Text] [Related]
9. [A study of the incorporation of 5-fluorouracil into transfer and ribosomal ribonucleic acids of yeast].
Giege R; Heinrich J; Weil JH; Ebel JP
Biochim Biophys Acta; 1969 Jan; 174(1):43-52. PubMed ID: 5766307
[No Abstract] [Full Text] [Related]
10. Studies on the synthesis of chemotherapeutics. 10. Synthesis and antitumor activity of N-acyl- and N-(alkoxycarbonyl)-5-fluorouracil derivatives.
Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Nagamatsu Y; Sugi H; Fukawa K; Irino O; Yamamoto T; Nishimura N; Taguchi A; Okada T; Nakayama M
J Med Chem; 1980 Dec; 23(12):1324-9. PubMed ID: 7452684
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of the fluoropyrimidines.
Myers CE
Pharmacol Rev; 1981 Mar; 33(1):1-15. PubMed ID: 6170079
[No Abstract] [Full Text] [Related]
12. Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil.
Buur A; Bundgaard H; Falch E
Acta Pharm Suec; 1986; 23(4):205-16. PubMed ID: 3799213
[No Abstract] [Full Text] [Related]
13. 5-fluorouracil.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():217-35. PubMed ID: 6944260
[No Abstract] [Full Text] [Related]
14. (o- and p-Nitrobenzyloxycarbonyl)-5-fluorouracil derivatives as potential conjugated bioreductive alkylating agents.
Lin TS; Wang L; Antonini I; Cosby LA; Shiba DA; Kirkpatrick DL; Sartorelli AC
J Med Chem; 1986 Jan; 29(1):84-9. PubMed ID: 3941417
[TBL] [Abstract][Full Text] [Related]
15. Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo.
Eaglstein WH; Weinstein GD; Frost P
Arch Dermatol; 1970 Feb; 101(2):132-9. PubMed ID: 5413250
[No Abstract] [Full Text] [Related]
16. Incorporation of 5-fluorouracil into the transfer RNA of Escherichia coli K12W6 and its effect on the methylation of uracil.
Baliga BS; Hendler S; Srinivasan PR
Biochim Biophys Acta; 1969 Jul; 186(1):25-32. PubMed ID: 4897215
[No Abstract] [Full Text] [Related]
17. Synthesis and in vivo antitumor activity of potential 5-fluorouracil prodrugs.
Rosowsky A; Kim SH; Trites D; Wick M
J Med Chem; 1982 Sep; 25(9):1034-40. PubMed ID: 7131481
[No Abstract] [Full Text] [Related]
18. Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil.
Buur A; Bundgaard H
J Pharm Sci; 1986 May; 75(5):522-7. PubMed ID: 3735094
[TBL] [Abstract][Full Text] [Related]
19. An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent.
Visser GW; Gorree GC; Braakhuis BJ; Herscheid JD
Eur J Nucl Med; 1989; 15(5):225-9. PubMed ID: 2759123
[TBL] [Abstract][Full Text] [Related]
20. The effect of bisulfite on the dehalogenation of 5-chloro-, 5-bromo-, and 5-iodouracil.
Sander EG; Deyrup CL
Arch Biochem Biophys; 1972 Jun; 150(2):600-5. PubMed ID: 5044041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
